These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22093996)

  • 1. Analysis and clinical correlation of genetic variation in cytomegalovirus.
    Lisboa LF; Tong Y; Kumar D; Pang XL; Asberg A; Hartmann A; Rollag H; Jardine AG; Pescovitz MD; Humar A
    Transpl Infect Dis; 2012 Apr; 14(2):132-40. PubMed ID: 22093996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients.
    Xia CS; Zhang Z
    Arch Virol; 2011 Jan; 156(1):17-23. PubMed ID: 20878191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
    Roubalová K; Strunecký O; Zufanová S; Procházka B; Vitek A
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
    J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients.
    Humar A; Siegal D; Moussa G; Kumar D
    J Infect Dis; 2005 Oct; 192(7):1154-7. PubMed ID: 16136456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants.
    Paradowska E; Jabłońska A; Studzińska M; Suski P; Kasztelewicz B; Zawilińska B; Wiśniewska-Ligier M; Dzierżanowska-Fangrat K; Woźniakowska-Gęsicka T; Czech-Kowalska J; Lipka B; Kornacka M; Pawlik D; Tomasik T; Kosz-Vnenchak M; Leśnikowski ZJ
    J Clin Virol; 2013 Sep; 58(1):271-5. PubMed ID: 23806667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
    Humar A; Kumar D; Boivin G; Caliendo AM
    J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.
    Benmarzouk-Hidalgo OJ; Cordero E; Martín-Peña A; García-Prado E; Gentil MA; Gomez-Bravo MA; Barrera-Pulido L; Cisneros JM; Perez-Romero P
    Antivir Ther; 2009; 14(5):641-7. PubMed ID: 19704166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae.
    Pignatelli S; Lazzarotto T; Gatto MR; Dal Monte P; Landini MP; Faldella G; Lanari M
    Clin Infect Dis; 2010 Jul; 51(1):33-41. PubMed ID: 20504230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
    Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
    J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay.
    Pang X; Humar A; Preiksaitis JK
    J Clin Microbiol; 2008 Dec; 46(12):4004-10. PubMed ID: 18971365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.
    Martin M; Goyette N; Ives J; Boivin G
    J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients.
    Lisboa LF; Preiksaitis JK; Humar A; Kumar D
    Transplantation; 2011 Nov; 92(9):1063-8. PubMed ID: 21878838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.
    Razonable RR; Åsberg A; Rollag H; Duncan J; Boisvert D; Yao JD; Caliendo AM; Humar A; Do TD
    Clin Infect Dis; 2013 Jun; 56(11):1546-53. PubMed ID: 23418272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.
    Gracia-Ahufinger I; Gutiérrez-Aroca J; Cordero E; Vidal E; Cantisán S; del Castillo D; Martín-Gandul C; Rivero A; Torre-Cisneros J
    Transplantation; 2013 Apr; 95(8):1015-20. PubMed ID: 23407543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
    Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.